Announced Fri, 26 Jun · 13:56 IST
Gland Pharma closes trading window ahead of Q1 results
Compliance View source PDF
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.0%1-day move
₹2313.00
prior close
₹2310.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5-0.2+0.3+1.9+7.0+7.0+6.0+6.2+7.2+8.1+6.3———
Up moveDown movePending
AI summary
Gland Pharma has closed its trading window from Saturday, June 27, 2026, in line with SEBI insider trading rules. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026. The board meeting date to approve the Q1 results has not been announced yet and will be shared later. This is a routine compliance filing and applies to insiders, directors, and employees of the company.
Likely market impact
Routine compliance filing. No material impact on shareholders. Watch for the upcoming Q1 results date, which could move the stock.